Caplin Point Laboratories Ltd Sustainability Reports

A fully integrated pharmaceutical company manufacturing and marketing a range of finished dosage forms, including generics, branded generics, and injectable products, primarily for emerging markets and regulated markets (US/EU).

Sector: Manufacturing

Country: India

Exchange: Bombay Stock Exchange

LEI: 33580043U3LXMROY5J69

FIGI: BBG001S8G5V6

8 reports from 2018 to 2026

• Caplin Point Laboratories Ltd 2026 Annual Report
• Caplin Point Laboratories Ltd 2025 Business Responsibility and Sustainability Report
• Caplin Point Laboratories Ltd 2024 Annual Report
• Caplin Point Laboratories Ltd 2024 Business Responsibility and Sustainability Report
• Caplin Point Laboratories Ltd 2023 Business Responsibility & Sustainability Report